IAA with FDA - Using big data to compare SARS-CoV-2 infection and therapeutic efficacy between human lung on a chip and animal model testing
|
Other
|
FDA
|
NIAID
|
2020
|
|
ICCVAM Ecotoxicology Workgroup (EcoWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2018
|
|
ICCVAM In Vitro to In Vivo Extrapolation Workgroup (IVIVE-WG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NLM
|
2017
|
|
ICCVAM Metrics Workgroup (MWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD
|
2019
|
|
ICCVAM Nanomaterials Workgroup (NanoWG)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
|
2018
|
|
ICCVAM Public Forum
|
Meeting/ Workshop
|
FDA
|
NCATS
|
2014
|
|
ICCVAM Read Across Workgroup (RAWG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NLM
|
2017
|
|
Identification and Validation of ctDNA Quality Control Materials
|
Resource Development
|
FDA
|
|
2019
|
|
IEEE Reporting Standards for In Vivo Neural Interface Research Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
|
2018
|
|
Image-guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI
|
2004
|
|
Imaging Core Unit
|
Research Initiative
|
FDA
|
NEI
|
|
|
Immune Responses to Influenza Vaccination
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Immunology Interest Group
|
Meeting/ Workshop
|
FDA
|
NIDDK, NHLBI, NIAID, NINDS, NIEHS, CC, NIAMS, NEI, NIDCR, NICHD, NIAAA, NIMH, NHGRI, NCCIH, NIA, NIDA, NIDCD, NIGMS, NIMHD, OD/ OIR
|
1990
|
|
Impact of Opioid-Related Emergencies on First Responders
|
Research Initiative
|
FDA
|
CC
|
|
|
Improving Genomics/Omics Technical Standards and Molecular Tools for Prebiotic Probiotic Research and Development Working Group
|
Research Initiative
|
CDC, FDA, OS
|
NCCIH, NCI, NHGRI, NIDA, NLM
|
2016
|
|
Improving Steps in the Development and Assessment of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs)
|
Other
|
FDA
|
NIAID
|
2019
|
|
In Silico Screening for Cancer Targets
|
Research Initiative
|
FDA
|
NCI
|
|
|
In Vitro Assessment of Dermal Hypersensitivity: Using Alternative Methods to Predict Skin Sensitization
|
Research Initiative
|
FDA
|
NIEHS
|
2018
|
|
In Vitro Assessment of Respiratory Hypersensitivity: Using Alternative Methods to Predict Respiratory Sensitization
|
Research Initiative
|
FDA
|
NIEHS
|
2022
|
|
Influenza Diagnostics Risk Management Meeting (FRMM) Strategy Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2018
|
|
Influenza Risk Management Meeting
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
Influenza Viral Pathogenesis
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Inhibition Of Renal Injury
|
Research Initiative
|
FDA
|
NIDDK
|
|
|
Innovation Equity Forum Steering Committee (IEF SteerCo)
|
Research Initiative
|
FDA
|
OD, NICHD, NHLBI, NINDS, NIGMS, FIC, NCATS, NIA, NCCIH
|
2022
|
|
Integrated Research Facility at Fort Detrick
|
Research Initiative
|
FDA
|
NIAID
|
|
|